O-1103 | H-γ-Glu-Gly-Gly-OH | C9H15N3O6 | 261.24 | 13640-39-6 | H-Glu(Gly-Gly-OH)-OH |
O-1104 | Ophthalmic Acid | C11H19N3O6 | 289.29 | 495-27-2 | H-Glu(Abu-Gly-OH)-OH |
O-1201 | Gliadorphin-7, α/β-Gliadin (43-49), GD-7, Prolamin (43-49), Gluteomorphin | C43H57N9O11 | 875.98 | 107936-65-2 | H-Tyr-Pro-Gln-Pro-Gln-Pro-Phe-OH |
O-1202 | C13H15N3O3 | 261.28 | 7360-09-0 | H-Trp-Gly-OH | |
O-1301 | Opiorphin | C29H48N12O8 | 692.78 | 864084-88-8 | H-Gln-Arg-Phe-Ser-Arg-OH |
O-1302 | (Pyr1)-Opiorphin | C29H45N11O8 | 675.75 | 1189350-60-4 | Pyr-Arg-Phe-Ser-Arg-OH |
O-1401 | Osteoblast Activating Peptide (human), OBAP (human) | C120H196N38O37S | 2795.18 | H-Leu-Asp-Leu-Asn-Leu-Glu-Leu-Ser-Lys-Phe-Arg-Met-Pro-Gln-Pro-Ser-Ser-Gly-Arg-Glu-Ser-Pro-Arg-His-OH | |
O-1402 | Osteoblast Activating Peptide (mouse, rat), OBAP (mouse, rat) | C120H196N38O37 | 2763.11 | 1222950-80-2 | H-Leu-Asp-Leu-Asn-Leu-Asp-Leu-Ser-Lys-Phe-Arg-Leu-Pro-Gln-Pro-Ser-Ser-Gly-Arg-Glu-Ser-Pro-Arg-His-OH |
P-0101 | Mitogenic Pentapeptide Pam3Cys-Ser-Ser-Asn-Ala-OH, Pam3CSSNA |
C67H124N6O14S | 1269.82 | 87173-03-3 | Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Ser-Asn-Ala-OH |
P-0102 | Pam3Cys-Ala-Gly-OH, Pam3CAG | C59H111N3O9S | 1038.61 | 117858-54-5 | Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH |